AMKOR TECHNOLOGY, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that AMKOR TECHNOLOGY, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $1.18B | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $1.08B | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $895.31M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $894.96M | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $1.08B | Feb 19, 2020 |
| FY2019 | Sep 30, 2018 | $1.14B | Feb 19, 2020 |
| FY2019 | Jun 30, 2018 | $1.07B | Feb 19, 2020 |
| FY2019 | Mar 31, 2018 | $1.03B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $1.15B | Feb 22, 2019 |
| FY2018 | Sep 30, 2017 | $1.15B | Feb 22, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.71B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $6.32B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $6.50B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $7.09B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $6.14B | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $1.37B | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $1.35B | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $1.17B | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $1.15B | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $1.18B | Feb 19, 2021 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.15B | Feb 23, 2018 |
| FY2017 | Sep 30, 2017 | $1.14B | Feb 23, 2018 |
| FY2017 | Jun 30, 2017 | $989.45M | Feb 23, 2018 |
| FY2017 | Mar 31, 2017 | $913.60M | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | $1.02B | Feb 23, 2018 |
| FY2017 | Sep 30, 2016 | $1.09B | Feb 23, 2018 |
| FY2017 | Jun 30, 2016 | $917.33M | Feb 23, 2018 |
| FY2017 | Mar 31, 2016 | $868.68M | Feb 23, 2018 |
| FY2017 | Dec 31, 2015 | $2.88B | Feb 23, 2018 |
| FY2016 | Dec 31, 2014 | $3.13B | Feb 24, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $938.60M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $933.21M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $943.15M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.33B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.23B | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $278.50M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $241.09M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $192.32M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $188.91M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $222.98M | Feb 19, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $373.90M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $354.01M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $359.81M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $765.82M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $643.00M | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $126.67M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $92.15M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $55.42M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $63.89M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $99.15M | Feb 19, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $467.39M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $438.46M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $470.29M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $897.19M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $763.43M | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | $159.18M | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | $127.47M | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | $86.52M | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | $84.07M | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $118.39M | Feb 19, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $166.74M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $162.95M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $177.47M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $149.43M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $166.04M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $140.73M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $137.64M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $157.18M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $166.63M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $117.21M | Feb 22, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $304.47M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $331.81M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $295.39M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $283.37M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $296.08M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $302.84M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $278.63M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $295.24M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $297.02M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $284.09M | Feb 22, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.10B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.09B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $1.27B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.10B | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $1.12B | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $770.03M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $563.85M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $663.41M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $618.27M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $729.40M | Feb 22, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $904.61M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $743.80M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $749.47M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $908.29M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $779.78M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $553.02M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $472.43M | Feb 18, 2022 |
| FY2020 | Dec 31, 2018 | $547.12M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $550.94M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $650.04M | Feb 22, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.14B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $6.94B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $6.77B | Feb 21, 2025 |
| FY2024 | Dec 31, 2022 | $6.82B | Feb 21, 2025 |
| FY2022 | Dec 31, 2021 | $6.04B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $5.02B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $4.70B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $4.50B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $4.51B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $4.09B | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.63B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.76B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.78B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.12B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $3.07B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.67B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $2.71B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $2.64B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $2.79B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $2.69B | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.47B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $4.15B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $3.96B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $3.67B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $2.94B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $2.33B | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $1.96B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.83B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $1.70B | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $1.38B | Feb 23, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.00M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $17.95M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $20.00M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $21.52M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $24.52M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $27.33M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $25.98M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $25.72M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $25.04M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $24.12M | Feb 23, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.63B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.34B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.16B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $1.87B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $1.16B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $562.50M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $234.08M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $113.19M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | ($13.90M) | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | ($303.56M) | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.38B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.13B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.12B | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | $959.07M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $826.74M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $698.00M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | $894.95M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $681.57M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $596.36M | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | $549.52M | Feb 23, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 16, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 19, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 247.30M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 246.68M | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | 245.89M | Feb 21, 2025 |
| FY2023 | Dec 31, 2022 | 245.09M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 244.32M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | 242.83M | Feb 18, 2022 |
| FY2020 | Dec 31, 2019 | 240.81M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 239.39M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 239,184 | Feb 22, 2019 |
| FY2017 | Dec 31, 2016 | 238,665 | Feb 23, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $81.95M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $178.61M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $74.69M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $55.12M | Feb 21, 2025 |
| FY2023 | Dec 31, 2021 | $51.21M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $0 | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $0 | Feb 18, 2022 |